Bridgeway Capital Management’s Avalo Therapeutics AVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-90	Closed	-$1.11M	–	1416
2018 Q1	$1.11M	Hold	90	–	–	0.01%	810
2017 Q4	$826K	Buy	+90	New	+$826K	0.01%	915